Reduning Injection and Atomization Inhalation Treatment of Bronchiolitis in 45 Cases

LV Rong-hua; HOU Ming; LI Su; LI Dao-kun

doi:10.11653/syfj2013200289

您当前的位置：

首页 >

文章列表页 >

Reduning Injection and Atomization Inhalation Treatment of Bronchiolitis in 45 Cases

更新时间：2024-01-04

- Reduning Injection and Atomization Inhalation Treatment of Bronchiolitis in 45 Cases
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 19, Issue 20, Pages: 289-292(2013)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.11653/syfj2013200289
  CLC：
- Published：2013
- 稿件说明：
移动端阅览
LV Rong-hua, HOU Ming, LI Su, et al. Reduning Injection and Atomization Inhalation Treatment of Bronchiolitis in 45 Cases[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(20): 289-292.
DOI：

LV Rong-hua, HOU Ming, LI Su, et al. Reduning Injection and Atomization Inhalation Treatment of Bronchiolitis in 45 Cases[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(20): 289-292. DOI： 10.11653/syfj2013200289.

摘要

目的: 探讨热毒宁注射液静脉滴注和雾化吸入治疗小儿毛细支气管炎的临床疗效及对炎性因子的影响。方法: 90例患儿随机按数字法分为观察组和对照组各45例。两组患儿均在西医常规处理的基础上

对照组采用布地奈德1 mg及特布他林5 mg加入生理盐水5 mL中通过氧气驱动雾化吸入;观察组采用热毒宁注射液静脉点滴及氧气驱动雾化吸入。疗程均为7 d。于第0、3天记录动脉血气指标;于第0、3、7天记录主要症状、体征;检测治疗前后血清白介素-8(IL-8)

白介素-6(IL-6)

肿瘤坏死因子-α(TNF-α)水平。结果: 观察组总有效率95.6%优于对照组的82.2%(P<0.05);第3天观察组血氧饱和度(SPO2)

氧分压(PaO2)均明显升高且高于对照组

PaCO2下降且低于对照组(P<0.01);第3天观察组发热、咳嗽、咯痰、喘憋及肺部听诊评分低于对照组(P<0.01);第7天

观察组咳嗽、咯痰、喘憋及肺部听诊评分低于对照组(P<0.01);观察组血清IL-6

IL-8及IFN-α水平均低于对照组(P<0.01)。结论: 采用热毒宁注射液静脉和雾化吸入治疗小儿毛细支气管炎临床疗效显著

作用机制可能与其减轻炎症反应相关。

Abstract

Objective: To discuss the clinical efficacy of treating pediatric capillary bronchitis with Reduning injection intravenous drip and Inhalation extra and the influence to inflammatory factors. Method: Ninety patients with pediatric capillary bronchitis were randomly divided into observation group (n=45) and control group (n=45). Patients in the two groups were both treated with conventional Western therapy. Patients in control group were treat with budesonide 1 mg and terbutaline 5 mg in physiological saline 5 mL by oxygen atomizing inhalation. Patients in observation group were given reduning injection intravenous drips and oxygen atomizing inhalation. Both groups were taken 7 day one cycle. The arterial blood gas index were recorded at 0 d and 3 days and the main symptoms and signs were recorded at 0

7 day;Serum interleukin-8 (IL-8)

interleukin-6 (IL-6)

tumor necrosis factor-α (TNF-α) levels were tested before and after treatment. Result: The total efficacy of the observation group 96.6% was significantly better than the control group 82.2% (P<0.05). Oxygen saturation(SPO2) and oxygen tension(PaO2) were both significantly higher at 3 day and observation group was higher than control group. PaCO2 of observation group was decline and was lower than control group(P<0.01). At 3 day

fever

cough

expectoration

wheezing suppress and lung auscultation score of observation group were lower than control group (P<0.01). At 3 day

cough

expectoration

wheezing suppress and lung auscultation score of observation group were lower than control group (P<0.01). Serum IL-6

IL-8 and TNF-α levels of observation group were lower than control group (P<0.01). Conclusion: Reduning injection intravenous micropump and inhalation extra has significant clinical efficacy and the mechanism may be related to reduce inflammation.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Reduning Injection， Shenfu Injection Combined with Gefitinib on Proliferation， Stemness Characteristics and Metabolism of Non-small Cell Lung Cancer Cells

Comparison of Pharmacokinetics between Reduning Injection and Geniposide Monomer in Rats

Systematic Review of Reduning Injection in Treatment of Hand-foot-mouth Disease

Application of Near-infrared Spectroscopy on Concentration Process of Gardeniae Fructus Extracting Solution from Reduning Injection

Effect of Clinical Efficacy, Lung Function and Inflammatory Cytokines of Reduning Injection Combined with Salmeterol and Fluticasone Propionate Inhalation Powder for Patients with Bronchial Asthma

Related Author

XIAO Zhenzhen

ZHU Yanjuan

YU Yaya

DING Lina

MA Changju

LEI Chenjing

LIU Yihong

CHANG Xuesong

Related Institution

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine （Guangdong Provincial Hospital of Chinese Medicine）

Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome

HongKong-Macao Joint Lab on Chinese Medicine and Immune Disease Research

The Second Clinical College of Guangzhou University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰